Dicks et al. reports on Leukocytoclastic vasculitis after COVID-19 mRNA vaccine booster (vascular medicine); 65-year-old man developed purpuric palpable lesions of the legs 2 days after receiving his
third dose of Pfizer BioNTech vaccination; Leukocytoclastic vasculitis (LCV); LCV is a cutaneous, small-vessel vasculitis characterized by deposition of immune complexes in the dermal capillaries
https://journals.sagepub.com/doi/epub/10.1177/1358863X211055507
‘With the mass vaccination effort to address the coronavirus disease 2019 (COVID-19) pandemic caused by the SARS-CoV-2, there have been numerous reports of cutaneous manifestations after receiving the SARS-CoV-2 vaccine, including those manufactured by Moderna, Pfizer BioNTech, and Johnson & Johnson. The most commonly reported cutaneous manifestations are vaccine-related eruption of papules and plaques (V-REPP), bullous pemphigoid-like, dermal hypersensitivity reactions, herpes zoster, lichen planus-like, and pernio.3 There have been case reports of the development of LCV after the Moderna and Pfizer BioNTech SARS-CoV-2 vaccines’
Alexander COVID News-Dr. Paul Elias Alexander’s Newsletter is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.
Go to Dr Alexancer on Substack
Author: Dr. Paul Alexander
